Rule · HKMA · 19 May 2014
Locally incorporated authorized institutions (AIs) must calculate their leverage ratio per the Basel III framework in Annex 1 and submit the completed Leverage Ratio Template to the HKMA by email at leverage.ratio@hkma.gov.hk as an Excel worksheet and as a signed hard copy to their usual supervisory contact, no later than 7 July 2014, and thereafter within 6 weeks of each March, June, September and December quarter-end, reporting quarter-end values to the nearest thousand in HK$ using closing middle market T/T rates. AIs required to report both combined and consolidated capital adequacy positions must make two submissions; those reporting only the combined position make one. Green formula cells must not be changed.
Our Ref.: B9/143C
B1/15C
19 May 2014
The Chief Executive
All locally incorporated authorized institutions Dear Sir / Madam, Implementation of Basel III – Quarterly Template for Reporting of Leverage Ratio I am writing to inform you that the HKMA has finalized the Leverage Ratio reporting package for locally incorporated authorized institutions (AIs) to report their leverage positions to the Authority on a quarterly basis. The final version of the template and associated completion instructions (which are enclosed for your ease of reference) can be downloaded at the HKMA private website (http://www.stet.iclnet.hk/index.htm). The first submission of the completed templates should cover the positions of both end-December 2013 and end-March 2014. AIs are required to submit the completed templates to the HKMA both in the form of an Excel worksheet through email at leverage.ratio@hkma.gov.hk, and in the form of a signed hard copy to their usual supervisory contact at the HKMA, by no later than 7 July 2014. System development is currently underway to enable AIs to submit the quarterly template via STET (potentially starting from the position of end-June 2014). We will be writing again to notify AIs of the detailed STET submission arrangements once the system is ready. Should you have any further queries concerning the above, please do not hesitate to contact Miss Theresa Kwan at 2878-1093 or Mr Raymond Tsui at 2878-1623. Yours faithfully,
Karen Kemp
Executive Director (Banking Policy)
Encl. c.c. The Chairman, The Hong Kong Association of Banks The Chairman, The DTC Association FSTB (Attn: Mr Jackie Liu)
| Determination of Capital Base ([Combined / Consolidated] position as of [30 September 2012 / 31 December 2012]) | ||||||||
|---|---|---|---|---|---|---|---|---|
| Name of authorised institution: ______________________________ | ||||||||
| Date of submission: _______________ | ||||||||
| Part II (a): | Capital Base | |||||||
| Column 1 | Column 2 | |||||||
| Item | Nature of item | HK$'000 | HK$'000 | Calculation / checking requirements | ||||
| Category I - Common Equity Tier 1 ("CET1") Capital | ||||||||
| (a) | Paid-up ordinary share capital | |||||||
| (b) | Share premium arising from item (a) | |||||||
| (c) | Retained earnings | |||||||
| (i) | of which: unaudited profit or loss of the current financial year and profit or loss of the | |||||||
| immediately preceding financial year pending audit completion | ||||||||
| (d) | Disclosed reserves | |||||||
| (i) | of which: available-for-sale investment reserve | |||||||
| (e) | Minority interests arising from issue of Common Equity Tier 1 capital instruments by | |||||||
| consolidated bank subsidiaries and held by third parties | ||||||||
| CET1 CAPITAL BEFORE DEDUCTIONS | (A) | (A) = sum ((a)…..(e)) in column 2 | ||||||
| (f) | Deduct: | |||||||
| (i) | Cumulative cash flow hedge reserves that relates to the hedging of financial instruments | |||||||
| that are not fair valued on the balance sheet | ||||||||
| (ii) | Cumulative fair value gains or losses on liabilities of the institution that are valued at fair | |||||||
| value and that result from changes in the own credit risk (excluding any debt valuation | ||||||||
| adjustments referred to in item (xii)) | ||||||||
| (iii) | Cumulative fair value gains arising from the revaluation of land and buildings (covering | |||||||
| both own-use and investment properties) | ||||||||
| (iv) | Regulatory reserve for general banking risk | |||||||
| (v) | Goodwill (net of related deferred tax liability) | |||||||
| (vi) | Other intangible assets (net of related deferred tax liability) | |||||||
| (vii) | Defined benefit pension fund assets (net of related deferred tax liability) | |||||||
| (viii) | Deferred tax assets in excess of deferred tax liabilities | |||||||
| (ix) | Gain-on-sale arising from securitization transactions | |||||||
| (x) | Securitization exposures specified in a notice given by the MA | |||||||
| (xi) | Valuation adjustments | |||||||
| (xii) | Debit valuation adjustments in respect of derivative contracts | |||||||
| (xiii) | Shortfall of provisions to expected losses | |||||||
| (For exposures calculated by using IRB approach for credit risk) | ||||||||
| (xiv) | Cumulative losses below depreciated cost arising from the institution's holdings of land | |||||||
| and buildings | ||||||||
| (xv) | Capital shortfall of regulated non-bank subsidiaries | |||||||
| (xvi) | Investments in own CET1 capital instruments | |||||||
| (xvii) | Reciprocal cross holdings in CET1 capital instruments issued by any | |||||||
| financial sector entities | ||||||||
| (xviii) | Capital investment in a connected company which is a commercial entity (amount of | |||||||
| the net book value of such investment in excess of 15% of the institution's capital base) | ||||||||
| (1) of which: any amount of loans, facilities or other credit exposures that is required | ||||||||
| by section 46(1) of Capital Rules to be aggregated with item (f)(xviii) | ||||||||
| (xix) | Insignificant capital investments in CET1 capital instruments issued by financial sector | |||||||
| entities that are not subject to consolidation under a section 3C requirement | ||||||||
| (1) of which: any amount of loans, facilities or other credit exposures that is required | ||||||||
| by section 46(2) of Capital Rules to be aggregated with item (f)(xix) | ||||||||
| (xx) | Significant capital investments in CET1 capital instruments issued by financial sector | |||||||
| entities that are not subject to consolidation under a section 3C requirement | ||||||||
| (1) of which: any amount of loans, facilities or other credit exposures that is required | ||||||||
| by section 46(2) of Capital Rules to be aggregated with item (f)(xix) | ||||||||
| For completion of return on a solo / solo-consolidated basis: | ||||||||
| (xxi) | Direct holdings of CET1 capital instruments issued by financial sector entities that | |||||||
| are members of the institution's consolidation group | ||||||||
| (1) of which: any loans, facilities or other credit exposures that is required by section | ||||||||
| 46(2) of Capital Rules to be aggregated with item (f)(xxi) | ||||||||
| (xxii) | Regulatory deductions applied to CET1 capital due to insufficient Additional Tier 1 capital | |||||||
| to cover the required deductions | ||||||||
| CET1 CAPITAL AFTER DEDUCTIONS | (B) | (B) = ((A) - sum ((f)(i)…..(f)(xxii))) in column 2 | ||||||
| Category II - Additional Tier 1 capital | ||||||||
| (g) | Additional Tier 1 capital instruments issued and share premium, if any | |||||||
| (i) | of which: amount that is subject to phase out | |||||||
| (h) | Applicable amount of Additional Tier 1 capital instruments issued by consolidated bank subsidiaries | |||||||
| and held by third parties | ||||||||
| (i) | of which: amount that is subject to phase out | |||||||
| ADDITIONAL TIER 1 CAPITAL BEFORE DEDUCTIONS | (C) | (C) = sum ((g)…..(h)) in column 2 | ||||||
| (i) | Deduct: | |||||||
| (i) | Investments in own Additional Tier 1 capital instruments | |||||||
| (ii) | Reciprocal cross holdings in Additional Tier 1 capital instruments issued by | |||||||
| financial sector entities | ||||||||
| (iii) | Insignificant capital investments in Additional Tier 1 capital instruments issued by financial | |||||||
| sector entities that are not subject to consolidation under a section 3C requirement | ||||||||
| (iv) | Significant capital investments in Additional Tier 1 capital instruments issued by financial | |||||||
| sector entities that are not subject to consolidation under a section 3C requirement | ||||||||
| For completion of return on a solo / solo-consolidated basis: | ||||||||
| (v) | Direct holdings of Additional Tier 1 capital instruments issued by financial sector | |||||||
| entities that are members of the institution's consolidation group | ||||||||
| (vi) | 50% of the total deductible amount applied to Tier 1 capital under transitional | Amount equals to 50% of the amount reported in item (21) | ||||||
| arrangements reported in Part II(b) | of Part II (b) | |||||||
| (vii) | Regulatory deductions applied to Additional Tier 1 capital due to insufficient | |||||||
| Tier 2 capital to cover the required deductions | ||||||||
| ADDITIONAL TIER 1 CAPITAL AFTER DEDUCTIONS | (D) | |||||||
| TIER 1 CAPITAL AFTER DEDUCTIONS (B) + (D) = | (E) | (E) = (B) + (D) in column 2 | ||||||
| Category III - Tier 2 capital | ||||||||
| (j) | Tier 2 capital instruments issued and share premium, if any | |||||||
| (i) | of which: amount that is subject to phase out | |||||||
| (k) | Applicable amount of Tier 2 capital instruments issued by consolidated bank subsidiaries and | |||||||
| held by third parties | ||||||||
| (i) | of which: amount that is subject to phase out | |||||||
| (l) | Reserve attributable to fair value gains on revaluation of holdings of land and buildings | |||||||
| (m) | Regulatory reserve for general banking risks | |||||||
| (For the portion apportioned to BSC approach and/or STC approach, and STC(S) approach) | ||||||||
| (n) | Collective provisions | |||||||
| (For the portion apportioned to BSC approach and/or STC approach, and STC(S) approach) | ||||||||
| (o) | Total of (m) & (n) included in Tier 2 Capital (Limited to 1.25% of risk-weighted amount for credit risks | |||||||
| related to BSC approach and/or STC approach, and STC(S) approach) | ||||||||
| (p) | Surplus provisions for exposures calculated by using IRB approach | |||||||
| (q) | The portion of an AI's total regulatory reserve for general banking risks and collective provisions | |||||||
| that is apportioned to the IRB(S) approach | ||||||||
| TIER 2 CAPITAL BEFORE DEDUCTIONS | (F) | (F) = sum (j) …..(q) in column 2 | ||||||
| (r) | Deduct: | |||||||
| (i) | Investments in own Tier 2 capital instruments | |||||||
| (ii) | Reciprocal cross holdings in Tier 2 capital instruments issued by financial sector entities | |||||||
| (iii) | Insignificant capital investments in Tier 2 capital instruments issued by financial sector | |||||||
| entities that are not subject to consolidation under a section 3C requirement | ||||||||
| (iv) | Significant capital investments in Tier 2 capital instruments issued by financial sector | |||||||
| entities that are not subject to consolidation under a section 3C requirement | ||||||||
| For completion of return on a solo / solo-consolidated basis: | ||||||||
| (v) | Direct holdings of Tier 2 capital instruments issued by financial sector entities that | |||||||
| are members of the institution's consolidation group | ||||||||
| (vi) | 50% of the total deductible amount applied to Tier 2 capital under transitional | Amount equals to 50% of the amount reported in item (21) | ||||||
| arrangements reported in Part II(b) | of Part II (b) | |||||||
| TIER 2 CAPITAL AFTER DEDUCTIONS | (G) | |||||||
| CAPITAL BASE (E) + (G) = | (H) | (H) = (E) + (G) in column 2 | ||||||
| TOTAL RISK-WEIGHTED AMOUNT | (I) | |||||||
| CET1 CAPITAL RATIO ((B) / (I)) * 100% = | (J) | (J) = (B) / (I) in column 2 * 100% (up to 2 decimal place) | ||||||
| TIER 1 CAPITAL RATIO ((E) / (I)) * 100% = | (K) | (K) = (E) / (I) in column 2 * 100% (up to 2 decimal place) | ||||||
| TOTAL CAPITAL RATIO ((H) / (I)) * 100% = | (L) | (L) = (H) / (I) in column 2 * 100% (up to 2 decimal place) |
| Part II (b): Breakdown of deductible items during transitional period | Capital Base | Part I (a): | Capital Base | Part I (a): | Capital Base | Part I (a): | Capital Base | Part I (a): | Capital Base | Part I (a): | Capital Base | Part I (a): | Capital Base | Part I (a): | Capital Base | Part I (a): | Capital Base | Part I (a): | Capital Base | Part I (a): | Capital Base | Part I (a): | Capital Base | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Column 1 | Column 2 | Column 3 | Column 4 | ||||||||||||||||||||||||||
| HK$'000 | HK$'000 | HK$'000 | HK$'000 | ||||||||||||||||||||||||||
| Item | Nature of item | Amount transitioned | Amount not yet transitioned | Total | |||||||||||||||||||||||||
| Risk-weight | 50:50 deduction | ||||||||||||||||||||||||||||
| Common Equity Tier 1 Capital | |||||||||||||||||||||||||||||
| (1) | Defined benefit pension fund assets | ||||||||||||||||||||||||||||
| (2) | Debit valuation adjustments in respect of derivative contracts | ||||||||||||||||||||||||||||
| (3) | Shortfall of provisions to expected losses | ||||||||||||||||||||||||||||
| (4) | Capital shortfall of regulated non-bank subsidiaries | ||||||||||||||||||||||||||||
| (5) | Investments in own CET1 capital instruments | ||||||||||||||||||||||||||||
| (6) | Reciprocal cross holdings in CET1 capital instruments issued by | ||||||||||||||||||||||||||||
| financial sector entities | |||||||||||||||||||||||||||||
| (7) | Capital investment in a connected company that is a commercial | ||||||||||||||||||||||||||||
| entity (amount of net book value of such investment in excess of | |||||||||||||||||||||||||||||
| 15% of the institution's capital base) | |||||||||||||||||||||||||||||
| (7)(a) | of which: any amount of loans, facilities or other credit exposures | ||||||||||||||||||||||||||||
| that is required by section 46(1) of Capital Rules to be aggregated | |||||||||||||||||||||||||||||
| with item (7) | |||||||||||||||||||||||||||||
| (8) | Insignificant capital investments in CET1 capital instruments | ||||||||||||||||||||||||||||
| issued by financial sector entities that are not subject to | |||||||||||||||||||||||||||||
| consolidation under a section 3C requirement | |||||||||||||||||||||||||||||
| (8)(a) | of which: any amount of loans, facilities or other credit exposures | ||||||||||||||||||||||||||||
| that is required by section 46(2) of Capital Rules to be aggregated | |||||||||||||||||||||||||||||
| with item (8) | |||||||||||||||||||||||||||||
| (9) | Significant capital investments in CET1 capital instruments | ||||||||||||||||||||||||||||
| issued by financial sector entities that are not subject to | |||||||||||||||||||||||||||||
| consolidation under a section 3C requirement | |||||||||||||||||||||||||||||
| (9)(a) | of which: any amount of loans, facilities or other credit exposures | ||||||||||||||||||||||||||||
| that is required by section 46(2) of Capital Rules to be aggregated | |||||||||||||||||||||||||||||
| with item (9) | |||||||||||||||||||||||||||||
| For completion of return on a solo / solo-consolidated basis: | |||||||||||||||||||||||||||||
| (10) | Direct holdings of CET1 capital instruments issued by financial sector | ||||||||||||||||||||||||||||
| entities that are members of the institution's consolidation group | |||||||||||||||||||||||||||||
| (10)(a) | of which: any amount of loans, facilities or other credit exposures | ||||||||||||||||||||||||||||
| that is required by section 46(2) of Capital Rules to be aggregated | |||||||||||||||||||||||||||||
| with item (10) | |||||||||||||||||||||||||||||
| Additional Tier 1 Capital | |||||||||||||||||||||||||||||
| (11) | Investments in own Additional Tier 1 capital instruments | ||||||||||||||||||||||||||||
| (12) | Reciprocal cross holdings in Additional Tier 1 capital instruments | ||||||||||||||||||||||||||||
| issued by financial sector entities | |||||||||||||||||||||||||||||
| (13) | Insignificant capital investments in Additional Tier 1 capital | ||||||||||||||||||||||||||||
| instruments issued by financial sector entities that are not subject | |||||||||||||||||||||||||||||
| to consolidation under a section 3C requirement | |||||||||||||||||||||||||||||
| (14) | Significant capital investments in Additional Tier 1 capital | ||||||||||||||||||||||||||||
| instruments issued by financial sector entities that are not subject | |||||||||||||||||||||||||||||
| to consolidation under a section 3C requirement | |||||||||||||||||||||||||||||
| For completion of return on a solo / solo-consolidated basis: | |||||||||||||||||||||||||||||
| (15) | Direct holdings of Additional Tier 1 capital instruments issued by | ||||||||||||||||||||||||||||
| financial sector entities that are members of the institution's | |||||||||||||||||||||||||||||
| consolidation group | |||||||||||||||||||||||||||||
| Tier 2 Capital | |||||||||||||||||||||||||||||
| (16) | Investments in own Tier 2 capital instruments | ||||||||||||||||||||||||||||
| (17) | Reciprocal cross holdings in Tier 2 capital instruments issued by | ||||||||||||||||||||||||||||
| financial sector entities | |||||||||||||||||||||||||||||
| (18) | Insignificant capital investments in Tier 2 capital instruments | ||||||||||||||||||||||||||||
| issued by financial sector entities that are not subject to | |||||||||||||||||||||||||||||
| consolidation under a section 3C requirement | |||||||||||||||||||||||||||||
| (19) | Significant capital investments in Tier 2 capital instruments | ||||||||||||||||||||||||||||
| issued by financial sector entities that are not subject to | |||||||||||||||||||||||||||||
| consolidation under a section 3C requirement | |||||||||||||||||||||||||||||
| (20) | For completion of return on a solo / solo-consolidated basis: | ||||||||||||||||||||||||||||
| Direct holdings of Tier 2 capital instruments issued by financial | |||||||||||||||||||||||||||||
| sector entities that are members of the institution's consolidation | |||||||||||||||||||||||||||||
| group | |||||||||||||||||||||||||||||
| (21) | The total deductible amount of items subject to 50:50 | ||||||||||||||||||||||||||||
| deduction during the transitional period | |||||||||||||||||||||||||||||
| [The sum of items (1) to (20) in Column 3, except items | |||||||||||||||||||||||||||||
| 7(a), (8)(a), (9)(a) and (10)(a)] |
Table truncated: columns after the first 30 not shown.
| SECRET | |||||
|---|---|---|---|---|---|
| Leverage Ratio | |||||
| Position Date : (Please select the position date) | 2013-12-31 | ||||
| Reporting Basis : (Please select "Combined" or "Consolidated") | Combined | ||||
| Name of Authorized Institution : | |||||
| Date of Submission : | |||||
| Notes on completion: | |||||
| 1. | Before completing the form, please read the completion instructions carefully. | ||||
| 2. | Please complete this form and return it to the Hong Kong Monetary Authority via STET not later than | ||||
| 6 weeks after the end of each quarter ending on 31 March, 30 June, 30 September and 31 December. | |||||
| To the best of our knowledge, the data in this form are correct. | |||||
| Chief Accountant | Chief Executive | ||||
| Name | Name | ||||
| Name and telephone number of responsible person who may be contacted by the Hong Kong Monetary | |||||
| Authority in case of any query | |||||
| Name | Telephone Number | ||||
| 2013-12-31 | Combined | ||||
| 2014-03-31 | Consolidated | ||||
| 2014-06-30 |
| Reporting of Leverage Ratio | |||||||
|---|---|---|---|---|---|---|---|
| Item | Nature of Item | Column 1 (HK$ '000) | Column 2 (HK$ '000) | Column 3 (HK$ '000) | |||
| Section 1: Exposure Measure | |||||||
| 0 | |||||||
| (1) | On-balance Sheet Exposures | ||||||
| (a) | Less: Regulatory adjustments | ||||||
| 0 | |||||||
| (2) | Derivative Exposures | ||||||
| (a) | Replacement cost associated with all derivatives transactions | ||||||
| (b) | Add-on amounts for potential future exposure associated with all derivatives transactions | ||||||
| (c) | Gross-up for collateral provided in respect of derivatives transactions | ||||||
| (d) | Adjusted effective notional amount of written credit derivatives | ||||||
| (e) | Less: Permitted reductions in notional amount and permitted deductions from add-on amounts for potential future exposure of written credit derivatives | ||||||
| (f) | Less: Receivables in respect of cash variation margin provided in derivatives transactions | ||||||
| (g) | Less: Exempted CCP legs of client-cleared trade exposures | ||||||
| 0 | |||||||
| (3) | Securities Financing Transaction (SFT) Exposures | ||||||
| (a) | Gross SFT assets, after adjusting for sales accounting transactions | ||||||
| (b) | Less: Netted amount of cash payables and cash receivables of gross SFT assets | ||||||
| (c) | Counterparty credit risk exposure for SFT assets | ||||||
| (d) | Agent transaction exposures | ||||||
| CCF (%) | 0 | ||||||
| (4) | Other Off-balance Sheet Exposures | ||||||
| 10 | 0 | ||||||
| (a) | Exposures with a 10% CCF for the calculation of Leverage Ratio | ||||||
| 20 | 0 | ||||||
| (b) | Exposures with a 20% CCF for the calculation of Leverage Ratio | ||||||
| 50 | 0 | ||||||
| (c) | Exposures with a 50% CCF for the calculation of Leverage Ratio | ||||||
| 100 | 0 | ||||||
| (d) | Exposures with a 100% CCF for the calculation of Leverage Ratio | ||||||
| Section 2: Calculation of the Leverage Ratio | |||||||
| 0 | |||||||
| (5) | Exposure Measure for the calculation of the Leverage Ratio | (A) | |||||
| (6) | Tier 1 Capital After Deductions | (B) | |||||
| (7) | LEVERAGE RATIO [((B) / (A)) * 100%] | (C) |
| Validation Rules | |
|---|---|
| Covering Page | |
| 1 | On covering page, position date, reporting basis, name of authorized institution, date of submission, name of Chief Executive and Chief Accountant as well as details of the name and telephone number of responsible person must be filled. No blank cells accepted. |
| Section 1: Exposure Measure | |
| (1) On-balance Sheet Exposures | |
| 2 | Item (1) in Column 1 - amount reported should be greater than or equal to zero. No blank cell accepted. |
| 3 | Item (1) in Column 3 = item (1) in Column 1 minus item (1)(a) in Column 2 |
| 4 | Item (1) in Column 3 - amount reported should be smaller than or equal to item (1) in Column 1. |
| 5 | Item (1)(a) in Column 2 - amount reported should be greater than or equal to zero. No blank cell accepted. |
| (2) Derivative Exposures | |
| 6 | Item (2) in Column 1 - amount reported should be greater than or equal to zero. No blank cell accepted. |
| 7 | Item (2) in Column 3 = the sum of item 2(a), 2(b), 2(c) and 2(d) in Column 2 minus item (2)(e), (2)(f) and (2)(g) in Column 2 |
| 8 | Item (2)(a) in Column 2 - amount reported should be greater than or equal to zero. No blank cell accepted. |
| 9 | Item (2)(b) in Column 2 - amount reported should be greater than or equal to zero. No blank cell accepted. |
| 10 | Item (2)(c) in Column 2 - amount reported should be greater than or equal to zero. No blank cell accepted. |
| 11 | Item (2)(d) in Column 2 - amount reported should be greater than or equal to zero. No blank cell accepted. |
| 12 | Item (2)(e) in Column 2 - amount reported should be greater than or equal to zero. No blank cell accepted. |
| 13 | Item (2)(f) in Column 2 - amount reported should be greater than or equal to zero. No blank cell accepted. |
| 14 | Item (2)(g) in Column 2 - amount reported should be greater than or equal to zero. No blank cell accepted. |
| (3) Securities Financing Transaction Exposures | |
| 15 | Item (3) in Column 1 - amount reported should be greater than or equal to zero. No blank cell accepted. |
| 16 | Item (3) in Column 3 = the sum of item (3)(a), (3)(c) and (3)(d) in Column 2 minus item (3)(b) in Column 2 |
| 17 | Item (3)(a) in Column 2 - amount reported should be greater than or equal to zero. No blank cell accepted. |
| 18 | Item (3)(b) in Column 2 - amount reported should be greater than or equal to zero. No blank cell accepted. |
| 19 | Item (3)(c) in Column 2 - amount reported should be greater than or equal to zero. No blank cell accepted. |
| 20 | Item (3)(d) in Column 2 - amount reported should be greater than or equal to zero. No blank cell accepted. |
| (4) Other Off-balance Sheet Exposures | |
| 21 | Item (4) in Column 3 = the sum of item (4)(a), (4)(b), (4)(c) and (4)(d) in Column 3 |
| 22 | Item (4) in Column 3 - amount reported should be smaller than or equal to the sum of item (4)(a), (4)(b), (4)(c) and (4)(d) in Column 1 |
| 23 | Item (4)(a) in Column 1 - amount reported should be greater than or equal to zero. No blank cell accepted. |
| 24 | Item (4)(a) in Column 3 = item (4)(a) in Column 1 * 10% |
| 25 | Item (4)(b) in Column 1 - amount reported should be greater than or equal to zero. No blank cell accepted. |
| 26 | Item (4)(b) in Column 3 = item (4)(b) in Column 1 * 20% |
| 27 | Item (4)(c) in Column 1 - amount reported should be greater than or equal to zero. No blank cell accepted. |
| 28 | Item (4)(c) in Column 3 = item (4)(c) in Column 1 * 50% |
| 29 | Item (4)(d) in Column 1 - amount reported should be greater than or equal to zero. No blank cell accepted. |
| 30 | Item (4)(d) in Column 3 = item (4)(d) in Column 1 |
| Section 2: Calculation of the Leverage Ratio | |
| 31 | Item (5) in Column 3 = sum of item (1), (2), (3) and (4) in Column 3 |
| 32 | Item (6) in Column 3 - amount reported should be greater than or equal to zero. No blank cell accepted. |
| 33 | Item (7) in Column 3 = [(Item (6) in Column 3 / Item (5) in Column 3) * 100%]. Ratio should be greater than zero. |
Quarterly Template on Leverage Ratio
Introduction
1 This document can be accessed on the BIS website : http://www.bis.org/publ/bcbs270.pdf Instead of following the submission timetable for CAR (which differs for the solo and the consolidated basis), a uniform submission timetable is adopted for both the solo and consolidated leverage position for simplicity.
This covers an AI and its subsidiaries that are required to be consolidated under a Section 3C requirement in the BCR.
10.1 An AI that is required to report both the combined position and the
consolidated position in respect of its capital adequacy ratio should make two submissions of the template as follows:
a submission based on the combined position, and a separate submission based on the consolidated position.
10.2 An AI that is only required to report the combined position in
respect of its capital adequacy ratio should make a single submission based on the combined position only. Definition and calculation methodology
11. AIs should refer to the calculation methodology described in Annex 1 for
computing the value of each reporting item. For ease of reference, the following table explains and links each of the reporting items in the template to the relevant paragraphs of Annex 1. Row Item Explanation / reference to
Annex 1 (paragraph nos.)
Section 1: Exposure Measure
(1) in column 1
On-balance Sheet Exposures 10.1(a), (b) and (c) (1)(a) in column 2 Less: Regulatory adjustments 10.1(d) (2) in column 1 Derivative Exposures Report the positive fair value of all derivative contracts (including those that are treated as off-balance sheet exposures under the applicable accounting standards) on a gross basis (without recognizing any netting that would otherwise be permitted under accounting standards or any credit risk mitigation effects). (2)(a) in column 2 Replacement cost associated with all derivatives transactions Replacement cost associated with all derivatives transactions, net of cash variation margin received (paragraph 10.2(g)(i)) and with, where applicable, bilateral netting according to paragraph 10.2(d).
Row Item Explanation / reference to
Annex 1 (paragraph nos.)
(2)(b) in column 2
Add-on amounts for potential future exposure associated with all derivatives transactions 10.2(b) to (d) (2)(c) in column 2 Gross-up for collateral provided in respect of derivatives transactions 10.2(e)(ii) (2)(d) in column 2 Adjusted effective notional amount of written credit derivatives 10.2(k) (2)(e) in column 2 Less: Permitted reductions in notional amount and permitted deductions from add-on amounts for potential future exposure of written credit derivatives 10.2(k) and (l) (2)(f) in column 2 Less: Receivables in respect of cash variation margin provided in derivatives transactions
10.2 (g)(ii)
(2)(g) in column 2
Less: Exempted CCP legs of client-cleared trade exposures 10.2(h) (3) in column 1 Securities Financing Transaction (SFT) Exposures Report the gross value of SFTs (without recognizing any netting of (cash) payables against (cash) receivables that would otherwise be permitted under accounting standards or any credit risk mitigation effects). (3)(a) in column 2 Gross SFT assets, after adjusting for sales accounting transactions Gross SFT assets with no recognition of any netting other than novation with QCCPs as set out in footnote 15, removing certain securities received as determined by the first bullet in paragraph 10.3(b)(ii) and adjusting for any sales accounting transactions as determined by paragraph
Row Item Explanation / reference to
Annex 1 (paragraph nos.)
10.3(b)(vi).
(3)(b) in column 2
Less: Netted amounts of cash payables and cash receivables of gross SFT assets The second bullet in paragraph 10.3(b)(ii) (3)(c) in column 2 Counterparty credit risk exposure for SFT assets 10.3(b)(iii) to (v). (3)(d) in column 2 Agent transaction exposures 10.3(c). (4) in column 3 Other Off-balance Sheet Exposures An auto-calculation row representing the credit equivalent amount of the institution’s offbalance sheet exposures. (4)(a) in column 1 Exposures with a 10% CCF for the calculation of the Leverage Ratio 10.4 (4)(b) in column 1 Exposures with a 20% CCF for the calculation of the Leverage Ratio 10.4 (4)(c) in column 1 Exposures with a 50% CCF for the calculation of the Leverage Ratio 10.4 (4)(d) in column 1 Exposures with a 100% CCF for the calculation of the Leverage Ratio 10.4
Section 2 – Calculation of the Leverage Ratio
(6) Tier 1 Capital After
Deductions
The amount reported in this row must be consistent with the figure reported for the same item in column 2 of Part II(a) of MA(BS)3(II). (7) Leverage Ratio An auto-calculation row representing the institution’s
Row Item Explanation / reference to
Annex 1 (paragraph nos.)
Leverage Ratio at the quarter-end.
Hong Kong Monetary Authority
May 2014
Leverage Ratio Framework
(A) Introduction
Definition
The Basel III Leverage Ratio (“LR”) is defined as the Capital Measure
(the numerator) divided by the Exposure Measure (the denominator), expressed as a percentage. Implementation
In accordance with the implementation timeline of the Basel Committee
on Banking Supervision (“BCBS”), the parallel run period for the LR commences on 1 January 2013 and continues until 1 January 2017. Public disclosure of the LR will start on 1 January 2015. The BCBS will make any necessary final adjustments to the definition and calibration of the LR by 2017, with a view to incorporating it as a Pillar 1 requirement under Basel III on 1 January 2018. During the parallel run period, a “testing minimum” LR of 3% has been set by the BCBS for the purpose of regulatory monitoring. (B) Capital Measure
The Capital Measure for the LR is Tier 1 capital1 calculated according to
Part 3 of the Banking (Capital) Rules (“BCR”), meaning that the
measure of Tier 1 capital should be net of any regulatory deductions applicable to Tier 1 capital, taking account of the Basel III transition arrangements, as specified under the BCR. (C) Exposure Measure Scope of consolidation
When calculated on a consolidated basis, the Exposure Measure of the
LR (the “Exposure Measure”) should cover exposures of group entities that are inside the scope of regulatory consolidation2 . In other words, the Basel III LR framework follows the same scope of regulatory consolidation as the risk-based capital framework. The BCBS will also continue to collect data during the transition period to track the impact of using either Common Equity Tier 1 or Total capital as the capital measure for the LR. This covers an AI and its subsidiaries that are required to be consolidated under a Section 3C requirement in the BCR.
Annex 1
In determining the Exposure Measure in respect of an AI’s investment in
other entities (“investees”), in cases where the investee is a financial sector entity or a commercial entity that is outside the scope of regulatory consolidation (in other words the investee is not included in an AI’s consolidation group pursuant to a section 3C requirement under the BCR), only the AI’s investment in the capital of the investee (i.e. only the carrying value of the AI’s investment and not the investee’s underlying assets and other exposures) must be included in the Exposure Measure of the AI.
However, investments in the capital of investees which are deducted
from the Tier 1 capital of the AI should also be excluded from the Exposure Measure of the AI. The AI’s investment in the entity may be excluded from the Exposure Measure of the AI to the same extent that it is deducted from the capital of the AI under section 43(1)(p) of the BCR in cases where the investee is a financial sector entity, or section 43(1)(n) in cases where the investee is a commercial entity that is a connected company of the AI. General Measurement Principles in respect of the Exposure Measure
An AI should generally follow the accounting measure of exposure for
the purposes of calculating the Exposure Measure, except that:
7.1 on-balance sheet, non-derivative exposures are to be included in
the Exposure Measure at accounting values, net of specific provisions and accounting valuation adjustments (e.g. accounting credit valuation adjustments);
7.2 netting of loans and deposits is not allowed; and
7.3 unless otherwise specified in this document, physical or financial
collateral, guarantees or other credit risk mitigation techniques must not be taken into account for reducing the Exposure Measure.
Exposures or assets deducted from Tier 1 capital should also be
deducted from the Exposure Measure (e.g. for IRB portfolios, the shortfall of the stock of provisions to expected losses that is deducted from the CET1 capital of the AI under section 43(1)(i) of the BCR should also be deducted from the Exposure Measure of the AI). Total Exposure Measure
An AI’s total Exposure Measure is the sum of the following exposures:
9.1 all on-balance sheet exposures;
9.2 derivative exposures (i.e. counterparty default risk exposure and
exposure to the reference asset);
9.3 SFT exposures, including where the AI acts as principal and
where the AI acts as agent and provides an indemnity or guarantee to one or both counterparties; and
9.4 other specified off-balance sheet exposures, including
commitments, direct credit substitutes, acceptances, standby letters of credit and trade letters of credit.
10. The methods for calculating the Exposure Measure in respect of the
above four main exposure categories are described in greater detail below:
10.1 On-balance sheet exposures
(a) For the purpose of calculating an AI’s Exposure Measure, the on-balance sheet exposures of an AI must include all onbalance sheet assets 3 . This includes on-balance sheet derivatives collateral and collateral for SFTs (i.e. which is recognised as an on-balance sheet asset under the applicable accounting standard), with the exception of on-balance sheet derivative and SFT assets as described under separate sections below. (b) Liability items (e.g. gains/losses on fair-valued liabilities or debit valuation adjustments on derivative liabilities due to changes in the AI’s own credit risk as described in sections 38(2)(b) and 43(1)(h) respectively of the BCR) must not be deducted from the Exposure Measure of an AI. (c) Where an AI is a note-issuing bank (which has the meaning assigned to it by section 2 of the Legal Tender Notes Issue Ordinance (Chapter 65 of the Laws of Hong Kong)), the AI’s on-balance sheet exposure shall not include, for the purpose of calculating the Exposure Measure, any certificates of indebtedness issued by the Financial Secretary pursuant to section 4 of the Exchange Fund 3 To avoid doubt, fiduciary assets can be excluded from the Exposure Measure provided that the assets meet the IAS 39 / HKAS 39 criteria for derecognition and, where applicable, IFRS 10 / HKAS 10 for deconsolidation.
Ordinance (Chapter 66 of the Laws of Hong Kong) to, and held by, the AI.
(d) Subject to the exceptions described in paragraph (b) above, on-balance sheet exposures deducted from Tier 1 capital (as set out in sections 38(a), (c), (d) and (e), 43 and 47 of the BCR) may be deducted from the Exposure Measure.4
10.2 Derivative exposures
Basic formula
(a) The Exposure Measure for derivative contracts consists of two components: (i) exposure arising from the underlying reference obligation of the derivative contract and (ii) counterparty default risk exposure. (b) AIs must calculate their counterparty default risk exposures5 , including where an AI sells protection using a credit derivative contract, as the sum of the current exposure 6 (“RC”) and potential future exposure (“PE”) (as described in paragraph (c) below) applying the bilateral netting rules7 as specified in the BCR (see paragraphs 6 to 8 of Appendix A) and adjusting the exposure amount for the related collateral as set out in paragraphs (e) to (g) below. Treatment of derivatives exposures arising out of transactions cleared through central counterparties (“CCPs”) is described in paragraphs (h) to (i) while written credit derivative contracts are subject to additional requirements as set out in paragraphs (j) to (l) below. (c) For a single derivative contract that is not covered by a valid bilateral netting agreement, the amount to be included in the 4 Where applicable, the deductions should include any shares issued by the AI by virtue of capitalizing property revaluation reserves that have been excluded from the institution’s CET1 capital under section 38(1)(a) of the BCR. This approach makes reference to the Current Exposure Method (CEM) which is used under the Basel II Framework to calculate counterparty credit risk exposure amounts associated with derivative exposures. The BCBS is considering alternatives to the CEM. If an alternative approach is adopted as a replacement for the CEM, the Committee will consider whether that alternative approach is appropriate for the LR in the context of the need to capture both types of exposure created by derivatives. Where there is no accounting measure of exposure for certain derivative instruments because they are held (completely) off-balance sheet, the bank must use the sum of positive fair values of these derivatives as the current exposure. For the purpose of determining the RC, AIs are permitted to recognize bilateral netting when a valid bilateral netting agreement is in place (although cross-product netting is not permitted).
Exposure Measure is determined as follows:
RC: The greater of the mark-to-market value of the contract and zero.
PE: an amount of potential future exposure over the remaining life of the contract calculated by multiplying the notional amount of the contract by the appropriate credit conversion factor (“CCF”). Where the notional amount is leveraged or enhanced by the structure of the contract, AIs must use the effective notional amount when determining PE. The CCFs for different types of derivative contract, including credit derivative contracts, are included in paragraphs 1 and 3 of Appendix A. Bilateral netting (d) For a set of derivative contracts covered by a valid bilateral netting agreement as defined in the BCR (see paragraph 6 of
Appendix A), the RC will be the net RC and the PE will be
“ANet” as calculated under the BCR (see paragraphs 7 and 8 of Appendix A).
Treatment of Collateral
(e) Subject to paragraphs (f) and (g) in calculating the Exposure Measure, the treatment of collateral described below applies regardless of whether the collateral is cash or non-cash; received or provided under contracts covered by a valid bilateral netting agreement; or in connection with derivative contracts traded on an exchange or through a central counterparty:
(i) Collateral Received (cash or non-cash) must not be netted against derivatives exposures irrespective of whether or not netting is permitted under the accounting rules or the BCR applicable to an AI. An AI must not reduce its Exposure Measure for a derivative contract by any collateral received from the counterparty. Exposure Measure = RC + PE
(ii) Collateral Provided (cash or non-cash) must not reduce an AI’s Exposure Measure. Where the provision of such collateral under the terms of a derivative contract has reduced an AI’s on-balance sheet assets under the applicable accounting standard, the AI must gross up its Exposure Measure by the amount of collateral provided. Treatment of cash variation margin (f) For the purpose of calculating the Exposure Measure, the cash portion of variation margin exchanged between counterparties may be viewed as a form of pre-settlement payment and may be used to reduce the Exposure Measure if the following conditions are met:
(i) For trades not cleared through a qualifying central counterparty (“QCCP”) 8 , the cash received by the recipient counterparty is not segregated. (ii) The cash variation margin is calculated and exchanged on a daily basis based on mark-to-market valuation of derivative positions. (iii) The cash variation margin is held in the same currency as the currency of settlement of the derivative contract. (iv) Variation margin exchanged is the full amount that would be necessary to fully extinguish the mark-tomarket exposure of the derivative subject to the threshold and minimum transfer amounts applicable to the counterparty. (v) Derivative transactions and the variation margins are covered by a single bilateral netting agreement between the legal entities that are counterparties in the derivative transaction. The bilateral netting agreement must explicitly stipulate that the counterparties agree to settle net any payment obligations covered by such a netting agreement, taking into account any variation margin received or provided, if a credit event occurs as to either counterparty. The bilateral netting agreement must be 8 “Qualifying CCP” is defined under section 226V(1) of the BCR.
legally enforceable and effective in all relevant jurisdictions, including in the event of default and bankruptcy or insolvency. (g) Subject to the conditions outlined in paragraph (f), the cash portion of variation margin received may be used to reduce the RC portion of the Exposure Measure, and the assets constituted by the receivable in respect of the cash variation margin provided may be deducted from the Exposure Measure as follows:
(i) in the case of cash variation margin received, the receiving AI may reduce the RC (but not the PE) of the exposure amount of the derivative asset by the amount of cash received if the positive mark-tomarket value of the derivative contract(s) has not already been reduced by the same amount of cash variation margin received under the accounting treatment applicable to the AI; (ii) in the case of cash variation margin provided to a counterparty, the posting AI may deduct the resulting receivable from its Exposure Measure, where the cash variation margin has been recognised as an asset under the accounting treatment applicable to the AI; (iii) cash variation margin may not be used to reduce the PE amount (and must not be taken into account in the calculation of the net-to-gross ratio as defined in paragraph 7 of Appendix A) Treatment of clearing services (h) Where an AI acting as clearing member (“CM”) 9 offers clearing services to clients, the CM’s trade exposures10 to the CCP that arise when the CM is obligated to reimburse the client for any losses suffered due to changes in the value of its transactions in the event that the CCP defaults, must be captured by applying the same treatment that applies to any other type of derivative transactions. However, if the CM, based on the contractual arrangements with the client, is not obligated to reimburse the client for any losses suffered due to changes in the value of its transactions in the 9 “Clearing member” is defined under section 2 of the BCR. 10 For the purposes of paragraphs (h) and (i), “trade exposures“ include initial margin irrespective of whether or not it is posted in a manner that makes it remote from the insolvency of the CCP.
event that a QCCP defaults, the CM need not recognise the resulting trade exposures to the QCCP in the Exposure Measure. (i) Where a client enters directly into a derivative transaction with the CCP and the CM merely guarantees the performance of its clients’ derivative trade exposures to the CCP, the AI acting as the CM for the client to the CCP must calculate its related Exposure Measure resulting from the guarantee as a derivative exposure as set out in paragraph
10.2 (a) to (g), as if it had entered directly into the
transaction with the client, including with regard to the receipt or provision of cash variation margin. Written credit derivative contracts (j) In addition to the CCR exposure arising from the fair value of the contracts, written credit derivative contracts create a notional credit exposure arising from the creditworthiness of the reference entity that has to be incorporated into the Exposure Measure in addition to the above treatments for derivative contracts, netting and collateral. (k) To capture the credit exposure to the reference entity, the notional amount11 of a written credit derivative contract, is incorporated into the Exposure Measure. However, the notional amount of a written credit derivative contract may be reduced by any negative change in fair value amount that has been incorporated into the calculation of Tier 1 capital with respect to the written credit derivative. Such resulting amount may be further reduced by the notional amount of a purchased credit derivative on the same reference name,12 13 11 For credit derivative contracts where the stated notional amount differs from the effective notional amount, AIs must use the greater of the effective notional amount and the notional amount. The effective notional amount is obtained by adjusting the notional amount to reflect the true exposure of contracts that are leveraged or otherwise enhanced by the structure of the transaction. 12 Two reference names are considered identical only if they refer to the same legal entity. For single name credit derivatives, protection purchased that references a subordinated position may offset protection sold on a more senior position of the same reference entity as long as a credit event on the senior reference asset would result in a credit event on the subordinated reference asset. Protection purchased on a pool of reference entities may offset protection sold on individual reference entities if the protection purchased is economically equivalent to buying protection separately on each of the individual entities in the pool. This would, for example, be the case if an AI were to purchase protection on an entire securitization structure. If an AI purchases protection on a pool of reference entities, but the credit protection does not cover the entire pool (i.e. the protection covers only a subset of the pool, as in the case of an nth-to-default credit derivative contract or a securitization tranche), then offsetting is not permitted for protection sold on individual reference entities. Such purchased protection may offset sold protection on a pool only if the purchased protection covers the entire subset of the pool on which protection has been sold. In other words, offsetting may only be recognized when the pool of reference entities and the level of subordination in both transactions are identical.
provided:
(i) the credit protection purchased is on a reference obligation which ranks pari passu with or is junior to the underlying reference obligation of the written credit derivative in the case of single name credit derivatives;14 and (ii) the remaining maturity of the credit protection purchased is equal to or greater than the remaining maturity of the written credit derivative. (l) To avoid overstatement of the Exposure Measure, an AI may deduct from the gross PE of all derivative contracts the PE of the written credit derivative contract if the contract is not offset by an eligible purchased credit derivative contract and the notional amount of the former contract is already included in the Exposure Measure. Where the written credit derivative contract is subject to a valid bilateral netting agreement, when calculating the “ANet”, “AGross” (as calculated under the BCR (see paragraph 7 of Appendix A)) may be reduced by the PE of the written credit derivative contract if its notional amount is already included in the Exposure Measure. However, no adjustments should be made to the net to gross ratio (“NGR”).
10.3 SFT Exposures
(a) The Exposure Measure calculations for SFTs distinguish between:
(i) situations where an AI is acting as principal; and (ii) situations where an AI is acting as agent and provides an indemnity or guarantee to one or both counterparties to the SFTs. 13 The notional amount of a written credit derivative may be reduced by any negative change in fair value reflected in the bank’s Tier 1 capital provided the effective notional amount of the offsetting purchased credit protection is also reduced by any resulting positive change in fair value reflected in Tier 1 capital. Where an AI buys credit protection through a total return swap (“TRS”) and records the net payments received as net income, but does not record offsetting deterioration in the value of the written credit derivative (either through reductions in fair value or by an addition to reserves) in Tier 1 capital, the credit protection will not be recognized for the purpose of offsetting the notional amounts related to written credit derivatives. 14 For tranched products, the purchased protection must be on a reference obligation with the same level of seniority.
(b) AI acting as principal
Basic Formula
Exposure Measure =
Gross SFT Assets + max {0, [Σ(Ei) –Σ(Ci)]}
(i) Where an AI is acting as principal on an SFT, the Exposure Measure is the sum of:
and (iii) bankruptcy; and
(C) The counterparties intend to settle net, settle simultaneously, or the transactions are subject to a settlement mechanism that results in the functional equivalent of net settlement, that is, the cash flows of the transactions are equivalent, in effect, to a single net amount on the settlement date. To achieve such equivalence, both transactions are settled through the same settlement system and the settlement arrangements are supported by cash and/or intra-day credit facilities intended to ensure that settlement of both transactions will occur by the end of the business day and the linkages to collateral flows do not result in the unwinding of net cash settlement.18 Bilateral netting (iii) With respect to a netting set of SFTs subject to a valid bilateral netting agreement (see paragraph 9 of
Appendix A), the current exposure for the netting set is
calculated as the greater of:
Sale Accounting Transactions
(vi) Leverage may remain with the lender of the security in an SFT whether or not sale accounting is achieved under the accounting framework. As such, where sale accounting is achieved for an SFT under the AI’s accounting framework, the AI must first reverse all sales-related accounting entries, and then calculate its exposure as if the SFT had been treated as a financing transaction under the accounting framework (i.e. in this last step, the AI must include the sum of amounts described in (i) above for such an SFT) for the purposes of determining its Exposure Measure. (c) AI acting as agent Basic Formula Exposure Measure = max {0, [Σ(Ei) – Σ(Ci)]} (i) If an AI acts as an agent in respect of an SFT (or a portfolio of SFTs) entered into by the AI’s customer and the AI provides an indemnity or guarantee to the customer for any difference between the value of the security or cash provided by the customer under the SFT (or SFTs) and the value of security or cash received by the customer, the AI will only be required to calculate its current exposure using the above formula.19 Exposure beyond indemnity / guarantee (ii) If, however, an AI’s exposure in respect of an SFT goes beyond an indemnity or a guarantee for the difference in value between the assets provided and received and includes exposure to the underlying cash or securities in the SFT, the AI will need to calculate its Exposure Measure as if it were acting as principal, i.e. by also including gross SFT assets recognized for accounting purposes. This would be the case where an AI manages collateral received in connection with an 19 Where an AI is acting as an agent in a SFT but does not provide an indemnity or guarantee to any of the involved parties, the AI is not exposed to the SFT and therefore need not recognize the SFT in its Exposure Measure.
SFT for its own account rather than for the customer’s account.
10.4 Other Off-balance Sheet Exposures
Basic Formula
Exposure Measure =
Amount of Off-balance Sheet Item x applicable CCF (a) The credit equivalent amount of an off-balance sheet item is generally calculated by multiplying the principal amount of the off-balance sheet item by a specific CCF as set out below. 20 CCFs Off-balance sheet items 10%
CCFs Off-balance sheet items
50%
Supplementary References for derivatives and securities financing transactions The LR framework generally follows the non-model based methodologies of the existing counterparty credit risk framework under the BCR for measuring the exposure amounts of derivative contracts and SFTs. For ease of reference, these are reproduced below in a form and language consistent with those employed for describing the LR framework. Derivative exposures CCFs for determining potential future exposure (“PE”)
The following CCFs apply to financial derivative contracts (other than
credit derivative contracts), based on residual maturity.
Residual maturity Interest rate
Exchange rate22
(including gold)
Equities
Precious metals
(except gold)
Other commodities
1 year or less 0.0% 1.0% 6.0% 7.0% 10.0%
Over 1 year to 5 years 0.5% 5.0% 8.0% 7.0% 12.0% Over 5 years 1.5% 7.5% 10.0% 8.0% 15.0% Notes:
For contracts with multiple exchanges of principal, the CCFs are to be multiplied by the number of remaining payments in the contract. For contracts that are structured to settle outstanding exposure following specified payment dates and where the terms are reset such that the market value of the contract is zero on these specified dates, the residual maturity would be set equal to the time until the next reset date. In the case of interest rate contracts with residual maturities of more than one year that meet the above criteria, the CCF is subject to a floor of 0.5%. Forwards, swaps, purchased options and similar derivative contracts not covered by any of the columns in this matrix are to be treated as “other commodities”. No PE would be calculated for single currency floating/floating interest rate swaps; the credit exposure on these contracts would be evaluated solely on the basis of their mark-tomarket value.
In the event that the stated notional amount is leveraged or enhanced by
the structure of the transaction, AIs must use the effective notional amount when determining PE. 22 To avoid doubt, exchange rate contracts with residual maturity of 1 year or less cover those with an original maturity of not more than 14 calendar days.
Appendix A
The following CCFs apply to single-name credit derivative contracts:
Protection buyer Protection seller
Total return swap
Qualifying reference obligation 5.0% 5.0%
Non-qualifying reference obligation 10.0% 10.0% Credit default swap Qualifying reference obligation 5.0% 5.0%* Non-qualifying reference obligation 10.0% 10.0%* There will be no difference depending on residual maturity.
(ii) the debt securities are assessed as equivalent to investment grade under the AI’s rating system; and (iii) the issuer of the debt securities (i) has securities listed on a recognized stock exchange or (ii) is subject to supervisory arrangements regarding the maintenance of adequate capital to support its business activities comparable to those prescribed for AIs under the Banking Ordinance and the BCR. Bilateral netting for derivatives transactions
6. For the purposes of the LR, the following will apply:
A bilateral netting agreement is considered a valid bilateral netting agreement if the following criteria are met:
(i) the agreement is in writing;
(ii) the agreement creates a single legal obligation for all individual contracts covered by the agreement, and provides, in effect, that an AI would have a single claim or obligation to receive or pay only the net amount of the sum of the positive and negative mark-tomarket values of the individual contracts covered by the agreement in the event that a counterparty to the agreement, or a counterparty to whom the agreement has been validly assigned, fails to comply with any obligation under the agreement due to default, insolvency, bankruptcy, or similar circumstance; (iii) the AI has been given independent legal advice in writing to the effect that in the event of a challenge in a court of law, including a challenge resulting from default, insolvency, bankruptcy, or similar circumstance, the relevant court or administrative authority would find the AI's exposure to be the net amount under—
that the agreement continues to satisfy this definition; (v) the AI manages the transactions covered by the agreement on a net basis; (vi) the AI maintains in its files documentation adequate to support the netting of the contracts covered by the agreement; and (vii) the agreement is not subject to a provision that permits the nondefaulting counterparty to make only limited payment, or no payment at all, to the defaulter or the estate of the defaulter, regardless of whether or not the defaulter is a net creditor under the agreement;
7. The counterparty default risk exposure in respect of derivative contracts
subject to a valid bilateral netting agreement with a counterparty will be calculated as the sum of net current exposure, if positive, and net PE. The net PE will be calculated by using the following formula:
ANet = (0.4 ×AGross) + (0.6 × NGR ×AGross) where:
ANet = the net PE
AGross = the sum of the individual PEs (calculated by multiplying the notional amount of each of the contracts by the appropriate CCF set out in paragraphs 1 to 3 above) of all the derivative contracts NGR = level of net replacement cost/level of gross replacement cost for the contracts
8. AIs must calculate the NGR either on a counterparty-by-counterparty basis
or on an aggregate basis for all contracts that are subject to valid bilateral netting agreements. Under the aggregate basis, the net replacement cost (that is the positive sum of the positive and negative replacement costs of the contracts) for each of the counterparties is aggregated. SFT exposures
9. The eligibility criteria for determining what constitutes a valid bilateral
netting agreement follow those set out in paragraph 6 above.
10. Netting across positions in the banking book and trading book will only be
recognised when the transactions fulfill the following conditions:
(a) All transactions are marked to market daily, and
(b) The collateral used in the transactions is recognized collateral in the banking book under the BCR.
Note from RegAlert. AI assistants can read this document in full, and search 70,000+ more, through the RegAlert MCP connector (https://mcp.regalert.today/mcp). Free with an account. How to connect ChatGPT, Claude or Cursor.
More like this from HKMA
HKMA published 5 documents in the last 30 days. We email you each new one the day it's published.
Source: Hong Kong Monetary Authority — original document · Summary generated with machine assistance and checked by an AI reviewer before publication; the authoritative text is the regulator's original document. How RegAlert works
In RegAlert: added